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Objective: To elucidate factors that contribute to the development of vancomycin resistance in methi-
cillin-resistant Staphylococcus aureus (MRSA).
Methods: Forty-nine MRSA isolates were subjected to passage selection with vancomycin to isolate
mutants with reduced susceptibility to vancomycin. One mutant was chosen for detailed molecular
and biochemical characterization.
Results: Five vancomycin-resistant mutants (vancomycin MICs, 6–12 mg/L) were obtained in vitro from
five MRSA parent isolates. Upon acquisition of vancomycin resistance, all mutants showed a concomi-
tant decrease in oxacillin resistance. In one particular MRSA strain, selection for vancomycin resist-
ance repeatedly produced deletions and rearrangements, including loss of the mecA gene. Pleiotropic
phenotypical changes, such as yellow pigment formation, loss of haemolysis, thickened cell wall,
increased resistance to lysostaphin and reduced cell wall turnover were observed in this mutant.
Conclusion: Acquisition of vancomycin resistance in one MRSA strain triggered mecA deletion
suggesting that this deletion, coupled to other rearrangements and/or mutations, may be responsible
for the increased vancomycin resistance phenotype.
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Introduction
In Staphylococcus aureus, resistance to methicillin and related
b-lactam antibiotics is encoded by the mecA gene, which is carr-
ied on a mobile genetic element termed the staphylococcal
chromosome cassette mec (SCCmec). The transfer of this element
is mediated by two site-specific recombinases, CcrA and CcrB,
which catalyse precise excision of SCCmec and its orientation-
specific integration into the chromosome of recipient cells.
The stability of SCCmec in S. aureus is influenced by
environmental factors. For example, spontaneous mecA deletion
has been observed during long-term storage in drug-free med-
ium,1 and in cultures that have been aged/starved, grown at high
temperatures, or given small doses of UV radiation.2,3 Spon-
taneous loss of SCCmec has also been reported to occur in some
lineages of S. aureus in vivo.4,5
Several reports have implicated a role for mecA in the devel-
opment of MRSA isolates with decreased susceptibility to
vancomycin. These studies have demonstrated a correlation
between decreased oxacillin resistance with a concomitant
increase in resistance to vancomycin either through the deletion
of mecA6 or mecA mutation.7
This study examined 49 clinical MRSA isolates for mutants
with decreased susceptibility to vancomycin after passage selec-
tion in vancomycin-containing medium. We report here that
vancomycin stress repeatedly triggered deletion of mecA in one
MRSA strain. This event coincided with a decrease in suscepti-
bility to vancomycin and pleiotropic phenotypic changes.
Materials and methods
Strains and culture conditions
The 49 MRSA isolates used in this study were a diverse collection of
clinical isolates from the culture collections of this laboratory and the
Environmental Science and Research, Communicable Disease
Centre, Porirua, New Zealand. S. aureus were defined as MRSA with
oxacillin MICs >_4 mg/L, and all were vancomycin-susceptible
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(MIC <_2 mg/L). All MICs of vancomycin and oxacillin were deter-
mined using Etests (AB Biodisk, Solna, Sweden) on Mueller–Hinton
agar (MHA-Difco, Detroit, MI, USA) containing 2% NaCl. Disc dif-
fusion sensitivity tests were carried out as described by the National
Committee for Clinical Laboratory Standards (NCCLS). Haemolytic
activity was sought by spotting 10mL of a 0.5 McFarland Standard
suspension on sheep blood agar plates with incubation for 24 h at
378C. The resulting growth was observed for their surrounding lytic
zones. Presence of b-lactamase was shown with nitrocefin discs
(Becton Dickinson, MD, USA).
Selection of mutants with decreased susceptibility
to vancomycin
For each of the 49 vancomycin-susceptible MRSA isolates, a single
colony was inoculated into 10 mL of tryptic soy broth (TSB) con-
taining 6 mg/L vancomycin and incubated at 378C until the optical
density (OD600, 1 cm light path) was >1.0. The resulting suspension
was then diluted to achieve a cell concentration of approximately
100 colonies per 100mL. Diluted cell suspensions (100mL) were
spread on to tryptic soy agar (TSA) plates containing the same con-
centration of vancomycin as the broth culture. Plates were then
incubated at 378C until colonies became evident, which took 1–7
days for positive isolates. Colonies were picked from plates that
exhibited good growth, excluding pinpoint colonies, and the cycle
of broth and agar growth was repeated three times with medium
containing the same concentration of vancomycin. With each repeat
passage, the time taken for colonies to appear on plates was reduced
to approximately 1–2 days for all isolates.
Pulsed-field gel electrophoresis
Pulsed-field gel electrophoresis (PFGE) of Sma I-digested DNA was
carried out to confirm that clonal identity was maintained between
each parent and the respective passaged mutant. PFGE was carried
out by contour-clamped homogeneous electric field (CHEF) electro-
phoresis using the CHEF-DRIII system (Bio-Rad Laboratories,
Richmond, CA, USA) as previously described.8 Gels were routinely
run at 6 V/cm, 148C, at an included angle of 1208, on a 1.2% aga-
rose gel (USB Corporation, Cleveland, OH, USA) with pulse times
of 5–35 s for 22 h. The Low Range PFG Marker (New England Bio-
labs, Inc., Beverly, MA, USA), containing lambda concatemers and
HindIII-digested lambda fragments, was used as a size standard.
All strains were tested for the presence of mecA by PCR and
Southern blot hybridization using standard protocols and primers as
previously described.8 Primer pair agr S3 (50-GATTTAAGTCGCA-
GTATTGGT-30) and agr S4 (50-ACGCGTCATATTTAATTTTGT-
30) were used to amplify a 1.2 kb amplicon containing agrC and
agrA.
Cell wall turnover, autolysis assays, lysostaphin
susceptibilities and transmission electron microscopy
Cell wall turnover was determined as described by Hanaki et al.9
using tritium-labelled N-acetylglucosamine ([3H]GlcNAc) and
measuring the release of radioactive cell wall components. Autolysis
activity of whole cells was determined by Triton X-100 treatment as
described by Mani et al.10 The cells were incubated at 308C with
shaking and the OD620 was measured at 60 min intervals for 4 h.
Lysostaphin (1 mg/L)-mediated cell lysis was carried out as
described by Peschel et al.11 The cells were incubated at 308C with
shaking and the OD620 was measured at 10 min intervals for 30 min.
The results shown for all experiments are the mean values of two to
four independent experiments that were carried out in triplicate. The
standard error of the mean did not differ by more than 15%. For
electron microscopy, strains were grown in 10 mL of TSB to the
late-log phase of growth to an OD600 around 1.0. Cells were pelleted
by centrifugation and fixed in 3% glutaraldehyde in 0.1 M phosphate
buffer (pH 7.0), with 3 mg/mL Ruthenium Red for 2 h at room temp-
erature. The cells were then washed in 0.1 M sodium cacodylate and
mixed for 5 min. This cycle was repeated a further two times. Cells
were then post-fixed in 2% osmium tetroxide with 3 mg/mL Ruthe-
nium Red in 0.1 M sodium cacodylate buffer (pH 7.0) for 2 h at
room temperature. Three more wash steps were then carried out,
and the cells stored at 48C overnight. Samples were then dehydrated
through an ethanol series and propylene-oxide, and embedded
in Agar 100 resin (Agar Scientific, Stansted, Essex, UK).
The embedded samples were sectioned (80 nm thick) and stained
with uranyl acetate and lead citrate. Grids were viewed with a trans-
mission electron microscope Akashi EM-002A at 100 kV accelerat-
ing voltage. Mean cell wall measurements were calculated from an
average of 30 cells.
Results
Acquisition of reduced susceptibility to vancomycin
is concomitant with deletion of mecA in MRSA strain 1126
To elucidate the factors that contribute to the development of
vancomycin resistance in MRSA, we subjected 49 clinical
MRSA isolates (all vancomycin-susceptible) to passage selection
with vancomycin. These 49 isolates consisted of: 15 isolates
(oxacillin MICs, >_128 mg/L) with identical Sma I macrorestric-
tion DNA profiles (group I); 24 isolates (oxacillin MICs, 4 to
>_128 mg/L) with PFGE patterns that differed by only one DNA
band (group II); and 10 isolates with distinct (>_6 band differ-
ences) PFGE patterns (oxacillin MICs, 8 to >_128 mg/L) (group
III). Based on these results, the 49 MRSA isolates selected for
this study represented a relatively diverse genetic group.
Upon passage in liquid medium containing 6 mg/L vanco-
mycin, five of 49 MRSA isolates yielded colonies after 1–7
days of incubation (Table 1). Two of the vancomycin-resistant
mutants, Vr6-1126a and Vr8-1128a, were derived from group I
MRSA isolates, and three (Vr6-1130a, Vr6-1132a and Vr12-
1134a) from group II MRSA isolates. The vancomycin MICs for
these mutants ranged from 6 to 12 mg/L (Table 1). These
mutants were termed with the prefix Vr followed by the number
indicating their vancomycin MIC. All corresponding parent iso-
lates were mecA-positive, with oxacillin MIC values >_128 mg/L,
and produced b-lactamase. The five Vr mutants exhibited
decreased resistance to oxacillin upon acquisition of vancomycin
resistance, but remained b-lactamase-positive.
Four of the five vancomycin-resistant mutants were positive
for mecA, but one mutant, designated Vr6-1126a, had lost mecA
(Table 1). In three independent experiments its parent MRSA,
isolate 1126, yielded mutants that had completely lost oxacillin
resistance. In this particular isolate, loss of oxacillin resistance
correlated with vancomycin MICs above 4 mg/L. All mutants
selected from strain 1126 were non-haemolytic and exhibited a
pale yellow pigmentation in contrast with the parent, which was
haemolytic and produced white colonies. Their vancomycin res-
istance remained stable after 10 passages in non-selective
medium.
PFGE analysis of mutants derived from strain 1126, and prob-
ing with mecA, revealed that those with vancomycin MICs
<_4 mg/L had the same PFGE pattern, termed 1a, as the parent
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strain (Figure 1, lanes 2, 4 and 5). In contrast, mutants with
vancomycin MICs >4 mg/L had lost mecA. This loss was associ-
ated with large deletions in the SCCmec-carrying Sma I–G band
(Figure 1, lanes 3, and 6–9), resulting either in a smaller
additional band I0 (Figure 1, lanes 3, 6, 7, and 9), or in a larger
band F0, presumably due to a deletion fusing Sma I–G to SmaI–I
in strain Vr10-1126a (Figure 1, lane 8).
Further analysis using the accessory gene regulator (agr)
locus as a DNA probe revealed additional rearrangements in the
Sma I–K band, which carried the agr operon (Figure 1, compare
panel a and c). According to the published sequence of S. aureus
N315 genome, agr maps in a region distant from the SCCmec
integration site, suggesting that deletion of SCCmec may have
induced loss of another genomic element, close to agr. This
SmaI–K band became either slightly larger (Figure 1, lane 3), or
became fused presumably to SmaI–J band to form a larger band
co-migrating with Sma I–F (Figure 1, lanes 6–9). These mutants
could be divided, based on the size of the deletion and their
restriction patterns, into three groups: pattern 1b (21 kb deletion),
represented by mutant Vr6-1126a (Figure 1, lane 3); pattern 1c
(93 kb deletion), represented by three mutants (Vr8-1126a,
Vr8-1126b and Vr8-1126c; Figure 1, lanes 6, 7 and 9), which is
similar to 1b, but with loss of Sma I–K; and pattern 1d (134 kb
deletion), represented by Vr10-1126a (Figure 1, lane 8).
To rule out the possibility that the deletion of mecA from
strain 1126 was due to a spontaneous event in the absence of
vancomycin, 30 individual cultures of 1126 were incubated for
10 days or more in TSB without daily passage at 378C. Approxi-
mately 200 colonies per culture were tested for oxacillin suscep-
tibility. Of 2000 colonies tested, only three mutants (0.15%)
with increased susceptibility to oxacillin were isolated. Two of
three mutants were negative for mecA, but their susceptibility to
vancomycin remained unchanged. The third mutant was still
positive for mecA and susceptible to vancomycin. In contrast,
the frequency of mecA deletion was 100% in vancomycin-
induced, 1126-derived mutants with vancomycin MICs >4 mg/L.
Hence, vancomycin triggered or selected for loss of mecA at a
much higher frequency.
A detailed comparative phenotypic analysis was carried out
between Vr6-1126a and its partially-isogenic parent 1126.
Figure 1. PFGE Sma I patterns of vancomycin-resistant mutants derived from parent strain 1126. (a) Lane 1, low range PFG marker (New England Biolabs);
lane 2, parent strain 1126; lane 3, Vr6-1126a; lane 4, Vr4-1126a; lane 5, Vr4-1126b; lane 6, Vr8-1126a; lane 7 Vr8-1126b; lane 8, Vr10-1126a; lane 9,
Vr8-1126c. The different banding patterns are indicated below each lane. (b) Southern hybridization of panel (a) with mecA; and (c) with agrCA.
Table 1. Vancomycin and oxacillin MICs for parent S. aureus isolates and vancomycin-
resistant mutants
Vancomycin-resistant mutants
MIC (mg/L)
Parent isolatea Oxacillin MIC (mg/L) Strain Vancomycin Oxacillin mecA
1126 >_128 Vr4-1126a 4 48 +
Vr4-1126b 4 1.5 +
Vr6-1126a 6 0.05 –
Vr8-1126a 8 0.2 –
Vr8-1126b 8 0.2 –
Vr8-1126c 8 0.1 –
Vr10-1126a 10 0.1 –
1128 >_128 Vr8-1128a 8 32 +
1130 >_128 Vr6-1130a 6 32 +
1132 >_128 Vr6-1132a 6 48 +
1134 >_128 Vr12-1134a 12 16 +
aAll parent MRSA were vancomycin-susceptible (MIC <2 mg/L) and positive for mecA.
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Mutant Vr6-1126a was more resistant to lysostaphin, and cell
wall turnover was markedly reduced in the mutant compared
with the parent (Table 2). The cell wall of Vr6-1126a was also
three-fold thicker than the parent strain (Table 2), but Triton
X-100-induced cell autolysis did not differ significantly.
Discussion
This study shows that vancomycin-induced stress can lead to the
deletion of mecA in some strains of MRSA. In the strain
reported here, this deletion correlated with increased resistance
to vancomycin, chromosomal rearrangements and pleiotropic
phenotypic changes. Subculturing of MRSA 1126 in non-
selective liquid medium gave rise to spontaneous mutants with
reduced oxacillin resistance at very low frequency (0.15%).
However, subculturing of strain 1126 in vancomycin-containing
medium triggered loss of mecA at a much higher frequency
(100%). Reipert et al.6 identified a spontaneous mutant of
methicillin-resistant vancomycin-intermediately-resistant S. aur-
eus, where an increase in vancomycin MIC correlated with loss
of a b-lactamase-encoding plasmid and a 32.5 kb deletion of
SCCmec, which extended 65.4 kb into the chromosomal DNA.
Hiramatsu et al.1 have hypothesized that penicillinase plasmids
may play a role in the stability and phenotypic expression of
mecA. However, it should be noted that the mecA deletion
mutants generated in our study remained b-lactamase-positive
and therefore appear to be novel.
The size of the mecA deletion in 1126 varied depending on
the mutant, and rearrangements in other parts of the chromo-
some (e.g. agr locus) were also observed. Some studies
have reported that clinical glycopeptide-intermediate S. aureus
(GISA) isolates are defective in the accessory gene regulator
(agr) locus.12 Whilst compromised agr function is not an absol-
ute requirement for the development of GISA, it appears to be
advantageous for the development of vancomycin hetero-
resistance.
The phenotypic properties of Vr6-1126a are consistent with
abnormalities in cell wall metabolism, as have been reported for
other vancomycin-resistant mutants. The results of this study
contribute further to our knowledge on the development of
vancomycin resistance in MRSA and we have shown that for
one MRSA strain, this results in the deletion of mecA at the
expense of vancomycin susceptibility. Future work will focus on
the apparent incompatibility between oxacillin and vancomycin
resistance in this strain.
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Table 2. Summary of phenotypic properties of MRSA 1126 and
Vr6-1126a
Strain/
mutanta
Cell wall
thickness
(nm)
Cell wall
turnover
(%)b
Autolytic
activity
(%)c
Lysostaphin
susceptibility
(%)d
1126 (parent) 26 81 68 5
Vr6-1126a 82 19 74 40
The results shown are the mean values of 2–4 independent experiments. The
standard error of the mean did not differ by more than 15%.
a1126 and Vr6-1126a were grown in the absence of vancomycin.
bExpressed as the percent radioactive cell wall components (CPM) released
into the culture supernatant after 90 min resuspension in isotope-free medium
containing 100 mg/L of cold N-acetylglucosamine.
cExpressed as percent remaining OD620 at 4 h after resuspension of culture in
autolysis assay buffer.
dExpressed as percent remaining OD620 at 30 min after resuspension of cul-
ture in assay buffer with lysostaphin (1mg/mL). Control tubes incubated
without lysostaphin showed less than a 10% decrease in OD620 during the
time course of the assay.
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